NCT03759678: A reported trial by IntraBio Inc
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03759678 |
|---|---|
| Title | Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 8, 2020 |
| Completion date | Feb. 11, 2025 |
| Required reporting date | Feb. 11, 2026, midnight |
| Actual reporting date | Jan. 20, 2026 |
| Date last checked at ClinicalTrials.gov | May 15, 2026 |
| Days late | None |